Duodenopancreatectomía cefálica por enfermedad maligna “borderline”: Resultados a corto y largo plazo de la resección vascular

Pancreatoduodenectomy is the standard treatment for malignant periampular neoplasms and malignant neoplasms of the pancreatic head, but most cases are not resectable at the time of diagnosis. Resectability may be increase by including vascular structures; but higher rates of complications and associated mortality risk have been reported. Objective. To report our results of Pancreatoduodenectomy associated with vascular resection. Material and methods. Retrospective review from January 2008 to September 2016. We analyzed demographic, tumor, vascular invasion, immediate postoperative complications, overall survival, and disease-free survival. For statistical analysis, SPSS® v.21 was used. (p < 0.05 was considered significant). Results. 74 pancreatoduodenec-tomies were performed due to primary malignant neoplasms. Twenty required vascular resection (RV). They were compared with 54 that did not require RV. There were no significant differences between groups in terms of age, sex, pathology and transfusion requirement. Median follow-up was 33 months (range: 0.2-112), the number of R0 resections was comparable between groups, global and disease-free survivals did not present significant differences (p = 0.10). Conclusions. VR increases the chances of obtaining an R0 resection without impacting peri-operative morbidity and mortality. In doing so, it expands the indication and applicability of surgery in patients with pancreatic cancer oncology, with or without previous neoadjuvancy.